Safety of Toremifene and Tamoxifen Therapy in Premenopausal Patients With Operable Breast Cancer
Status:
Completed
Trial end date:
2018-08-01
Target enrollment:
Participant gender:
Summary
To compare the safety of toremifene and tamoxifen therapy in premenopausal patients with
operable breast cancer by monitoring gynecological abnormality,blood lipid level,hepatic
abnormality,estrogen level and perimenopausal symptoms.